< Back to previous page
Researcher
Daan Dierickx
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Hematology (Division)
Responsible
From1 Oct 2019 → Today - Laboratory of Experimental Hematology (Division)
Member
From1 Oct 2013 → Today
Projects
1 - 10 of 15
- Molecular characterization of hyperactive T cell receptor signaling in peripheral T cell lymphoma to uncover druggable targetsFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular characterization of genetic events driving development of peripheral T cell lymphomaFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- GAINING INSIGHT IN THE MUTATIONAL PROFILE OF PT-DLBCL AND ASSESSING ITS BIOLOGICAL EFFECTS AND TRANSFORMING POTENTIALFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular characterization of rare lymphomas to uncover new biomarkers and treatment targets.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Degradation of CDK1 and HDACs as a strategy to treat T-cell malignanciesFrom1 Oct 2023 → TodayFunding: BOF - projects
- Characterization of non-canonical EZH2 transcriptional complexes to identify new therapeutic targets in peripheral T cell lymphoma.From1 Sep 2023 → TodayFunding: Other federal public and semi-governmental institutions
- Molecular characterization of genetic events driving development of peripheral T cell lymphomaFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Molecular characterization of hyperactive T cell receptor signaling in peripheral T cell lymphoma to uncover druggable targetsFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Viral Oncology: molecular biology and pathogenesis of post-transplant lymphoproliferative disorder (PTLD)From13 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Extensive preclinical validation of combinations of targeted treatment for peripheral T cell lymphomaFrom10 Aug 2021 → 30 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 203
- Blood smear and fluorescence based platelet count are keyin a case of cryoglobulin masked thrombocytopenia(2023)
Authors: Nancy Boeckx, Daan Dierickx
- The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)(2023)
Authors: Daan Dierickx
Pages: 1944 - 1951 - Not all black colons on [18F]FDG PET are due to metformin(2023)
Authors: Vibeke Vergote, Daan Dierickx, Thomas Tousseyn, Didier Bielen, Koen Van Laere, Christophe Deroose, Karolien Goffin
Pages: 3477 - 3478 - Safety and performance of the Spectra Optia apheresis system for white blood cell depletion in patients with elevated white blood cell counts(2023)
Authors: Daan Dierickx
Pages: 396 - 405 - Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies(2023)
Authors: Daan Dierickx, Kathleen Claes
Pages: 881 - 891 - KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma.(2023)
Authors: Daan Dierickx
- Tabelecleucel for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease After Failure of Rituximab ± Chemotherapy Following Solid Organ or Allogeneic Hematopoietic Cell Transplant (ALLELE)(2023)
Authors: Daan Dierickx
Pages: S589 - S589 - Effectiveness and safety outcomes in patients with EBV+ PTLD treated with allogeneic EBV-specific T-cell immunotherapy (tabelecleucel) under an expanded access program (EAP) in Europe.(2023)
Authors: Daan Dierickx
- [18F]FDG-PET/CT volumetric parameters can predict outcome in untreated mantle cell lymphoma(2023)
Authors: Vibeke Vergote, Gregor Verhoef, Ann Janssens, Annouschka Laenen, Thomas Tousseyn, Daan Dierickx, Christophe Deroose
Pages: 161 - 170 - Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 Years(2022)
Authors: Vibeke Vergote, Christophe Deroose, Steffen Fieuws, Wim Laleman, Anne Uyttebroeck, Gregor Verhoef, Robin Vos, Thomas Tousseyn, Daan Dierickx